Cellumed

At a glance

Cellumed filed 76 disclosures in the last 12 months, including 4 5% holder, 1 insider and 1 issuance. The most recent key filing was on Mar 23: A major holder's stake rose from 0.00% to 0.00% (pledge).

Revenue for 2025 was ₩140B, up 8.6% on 2024. It made an operating loss of ₩5.1B. Debt was 626% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩54.2B and operating loss of ₩13.1M.

The 2025 annual report lists 83 employees with an average tenure of 4.5 years and average pay of ₩48.3M, #1816 of 2,191 listed companies by average pay. Its 5 directors and auditors were paid ₩104M each on average. It paid no cash dividend for 2025. (주)인스코비 and related parties held 23.49% at year end.

Of 4 recent 5%+ holder reports, 1 raised and 2 cut a stake; the largest stake reported was 33.91% on Jan 28.

From the 2025 annual report

Staff: 83 (45 men, 38 women), of whom 3 on fixed-term contracts. Total pay for the year: ₩4B. Directors and auditors: 5, paid ₩522M in total.

No cash dividend was paid for 2025.

Largest shareholder

(주)인스코비 holds 18.31%; with 5 related parties the group holds 23.49% of common shares at year end (from 27.50% at the start of the year).

Auditor: 이정회계법인 · opinion: Disclaimer of opinion.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

5%+ holder reports